Serum glutathione reductase level as a disease activity biomarker in systemic lupus erythematosus: a single-centre preliminary study
Objectives This study aimed to investigate serum glutathione reductase (GR) levels in patients with SLE and to assess its association with disease activity.Methods The retrospective study collected clinical data, including serum GR, complement (C) 3 and C4 levels, among patients with SLE. The SLE Di...
Saved in:
Main Authors: | Yan Sun, Leixi Xue, Zhichun Liu, Mengxue Yan, Siping Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-06-01
|
Series: | Lupus Science and Medicine |
Online Access: | https://lupus.bmj.com/content/12/1/e001593.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biochemical study of glutathione reductase (GSH-Red) in Tissue Homogenate of Breast Tumors
by: Baghdad Science Journal
Published: (2009-06-01) -
Atherogenic effect of systemic lupus erythematosus pts blood serum
by: Z S Alekberova, et al.
Published: (2003-06-01) -
Glucocorticoid toxicity index in patients with systemic lupus erythematosus (preliminary data)
by: E. V. Ermolaeva, et al.
Published: (2024-02-01) -
Serum 3-Nitrotyrosine in the Cardiovascular Disease of Patients with Systemic Lupus Erythematosus
by: Juan C. Quevedo-Abeledo, et al.
Published: (2025-06-01) -
Clinical significance of interferon status in patients with systemic lupus erythematosus. Preliminary data
by: T. A. Panafidina, et al.
Published: (2025-03-01)